SAGASIGN
LIVE

Serial Number

79297241

Owner

SAGA Diagnostics AB

Attorney

Sarah J. Schneider

Filing Date

Mar 5, 2020

Add to watchlist:

No watchlists yet
View on USPTO

SAGASIGN Trademark

Serial Number: 79297241 • Registration: 6350878

SAGASIGN is a trademark filed by SAGA Diagnostics AB on March 5, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

SAGA Diagnostics AB (6 trademarks)

Medicon Village,

Entity Type: 03

Trademark Details

Filing Date

March 5, 2020

Registration Date

May 18, 2021

Published for Opposition

March 2, 2021

Goods & Services

Genetic counseling; genetic testing of animals for diagnostic or treatment purposes; laboratory analysis being medical analysis for diagnostic and treatment of persons provided by medical laboratories; medical and healthcare services; medical monitoring of patients; stem cell therapy services; medical services; analysis of human serum for medical treatment; analysis of human tissues for medical treatment; blood bank services; bowel cancer screening services; breast cancer screening services; cervical cancer screening services; colonoscopy screening services; medical consultancy and information services relating to medical products; DNA screening for medical purposes; genetic testing for medical purposes; hepatitis screening services; lung cancer screening services; medical advice in the field of pregnancy; medical analysis for the diagnosis and treatment of persons relating to cancer and infectious diseases; medical analysis services for the diagnosis of cancer; medical analysis services for cancer diagnosis and prognosis; medical analysis services for the diagnosis of cancer; medical analysis services relating to the treatment of patients relating to cancer and infectious diseases; medical analysis services relating to the treatment of persons for cancer and infectious diseases provided by a medical laboratory; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical and health services relating to DNA, genetics and genetic testing; medical care and analysis of cancer diagnosis relating to patient treatment; medical consultations; medical diagnostic services; medical evaluation services; medical analysis services for diagnostic and treatment purposes of blood samples taken from patients provided by medical laboratories; medical screening; medical services for the treatment of skin cancer; medical services in the field of oncology; medical testing for diagnostic or treatment purposes; medical testing services relating to the diagnosis and treatment of disease; prostate cancer screening services; providing cancer screening services; providing information in the field of medicine; RNA or DNA analysis for cancer diagnosis and prognosis; services for the testing of blood; services for the testing of sera; services for the testing of urine; services for the preparation of medical reports relating to health care; technical consultancy services relating to medical health; testicular cancer screening services

Analysis of human serum for medical research; analysis of human tissues for medical research; biological research, clinical research in the field of cancer and infectious diseases and medical research; clinical research in the field of cancer and infectious diseases; clinical trials for others; conducting early evaluations in the field of new pharmaceuticals; consultancy relating to laboratory testing; consultancy relating to pharmaceutical research and development; medical laboratory services; medical research; medical research laboratory services; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; providing information about the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing scientific information in the field of medical disorders and their treatment; provision of information and data relating to medical and veterinary pharmaceutical and diagnostic research and development; research and development for the pharmaceutical industry; research and development in the pharmaceutical and biotechnology fields; scientific research and development; scientific research for medical purposes in the area of cancerous diseases; services for assessing the efficiency of pharmaceuticals; services for assessing the efficiency of veterinary drugs

Nucleic acid sequences for medical and veterinary purposes; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing; diagnostic preparations and materials, namely, medical diagnostic reagents; chemical preparations for testing blood for medical purposes; chemical preparations for use in DNA analysis for medical purposes; chemical reagents for medical or veterinary purposes; chemical reagents for medical use; chemical reagents for veterinary use; chemical test reagents for medical purposes; chemical test reagents for veterinary purposes; clinical medical reagents; diagnostic agents for medical use; diagnostic biomarker reagents for medical purposes; diagnostic chemical reagents for medical use; diagnostic preparations for medical or veterinary purposes; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic reagents for medical use; diagnostic testing materials for medical use; genetic identity tests comprised of reagents for medical purposes; in vitro diagnostic preparations for medical use; medical diagnostic reagents and assays for testing of body fluids; medical diagnostic test strips for analysis of blood and other liquids; preparations for detecting genetic predispositions for medical purposes; preparations for detecting mutation in prion genes for medical purposes; reactants for medical diagnosis being diagnostic reagents for medical purposes; reagents and media for medical and veterinary diagnostic purposes; reagents for analytical purposes for medical purposes; reagents for analytical purposes for veterinary purposes; reagents for blood grouping for medical purposes; reagents for in-vitro laboratory use for medical purposes; reagents for in-vitro laboratory use for veterinary purposes; reagents for microbiological analysis for medical purposes; reagents for microbiological analysis for veterinary purposes; reagents for use in analysis for medical purposes; reagents for use in analysis for veterinary purposes; reagents for use in diagnostic tests for medical purposes; reagents for use in diagnostic tests for veterinary purposes; reagents for use with analyzers for medical purposes; reagents for use with analyzers for veterinary purposes; reagents for use in diagnostic pregnancy tests; veterinary diagnostic reagents

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 18, 2026 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jul 24, 2023 NREP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 15, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 15, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 15, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 15, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 15, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 15, 2022 COAR
NEW REPRESENTATIVE AT IB RECEIVED
Jan 21, 2022 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 25, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 3, 2021 FICS
FINAL DISPOSITION PROCESSED
Sep 3, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 18, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
May 18, 2021 R.PR
NOTIFICATION PROCESSED BY IB
Mar 15, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 2, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 2, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 24, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 24, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 10, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 22, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 31, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 30, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 30, 2020 TROA
REFUSAL PROCESSED BY IB
Dec 20, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 3, 2020 RFCS
REFUSAL PROCESSED BY MPU
Dec 3, 2020 RFRR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 19, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 19, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 19, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 19, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 19, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 19, 2020 COAR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 17, 2020 RFCR
NON-FINAL ACTION WRITTEN
Nov 16, 2020 CNRT
NEW REPRESENTATIVE AT IB RECEIVED
Nov 13, 2020 NREP
APPLICATION FILING RECEIPT MAILED
Nov 10, 2020 MAFR
ASSIGNED TO EXAMINER
Nov 6, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 6, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 5, 2020 REPR